Latest Litigation Risk News

Page 2 of 2
Transurban reports solid FY25 financial results with strong EBITDA and free cash flow growth, steady operating costs, and promising progress on NSW Toll Reform and major infrastructure projects.
Nora Hopper
Nora Hopper
20 Aug 2025
ResMed Inc. reported a robust 10% increase in revenue to $5.15 billion for fiscal 2025, driven by strong demand in sleep and breathing health devices and residential care software. The company also expanded its diagnostic capabilities with the acquisition of VirtuOx, positioning itself for further growth in home-based health solutions.
Ada Torres
Ada Torres
11 Aug 2025
Power Minerals Limited has launched a new options offer linked to a recent $1.3 million placement, alongside updates on key project acquisitions and divestments. The prospectus outlines significant risks and strategic directions as the company navigates growth and financial challenges.
Maxwell Dee
Maxwell Dee
2 July 2025
Treasury Wine Estates has secured Supreme Court approval for a $65 million settlement of a consolidated shareholder class action, allowing the company to focus on its strategic goals without admitting liability.
Victor Sage
Victor Sage
24 June 2025
Macarthur Minerals Limited has issued a replacement prospectus for a renounceable entitlement offer aiming to raise approximately AUD 2 million, fully underwritten by Gold Valley Yilgarn Pty Ltd. The offer includes free attaching options and supports the company’s exploration and operational funding needs.
Maxwell Dee
Maxwell Dee
13 June 2025
Mayne Pharma rebuffs Cosette's claim of a material adverse change in their merger scheme and secures FDA clearance on regulatory concerns, maintaining its commitment to the deal's completion.
Ada Torres
Ada Torres
4 June 2025
ALS Limited has announced a fully underwritten A$350 million equity placement to fund major upgrades to its global laboratory network and support future growth initiatives, aiming for mid single-digit EPS accretion by FY25 pro forma.
Victor Sage
Victor Sage
27 May 2025
Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.
Ada Torres
Ada Torres
15 May 2025
Fletcher Building reported a challenging HY25 with a 7% revenue decline and a net loss of NZ$134 million, while executing a $700 million equity raise to strengthen its balance sheet and advancing significant cost reduction initiatives.
Victor Sage
Victor Sage
19 Feb 2025
Smart Parking Limited has reported robust H1 FY25 results, underpinned by a strategic acquisition of Peak Parking LP and a fully underwritten $45 million equity raise to fund its US expansion.
Sophie Babbage
Sophie Babbage
17 Feb 2025
Energy Transition Minerals Ltd has issued a prospectus offering up to 68.75 million free-attaching quoted options to placement participants as part of a $9.35 million capital raising. The options, exercisable at $0.12 and expiring in 18 months, aim to support expansion in Greenland and project development despite ongoing litigation risks.
Maxwell Dee
Maxwell Dee
24 Jan 2025